HENGRUI PHARMA (01276) announced that on September 11, 2025, the company conducted a share repurchase program, acquiring 235,000 A-shares at a total cost of RMB 15.9266 million. The repurchase price ranged between RMB 67.2 and RMB 68.41 per share.
HENGRUI PHARMA (01276) announced that on September 11, 2025, the company conducted a share repurchase program, acquiring 235,000 A-shares at a total cost of RMB 15.9266 million. The repurchase price ranged between RMB 67.2 and RMB 68.41 per share.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.